摘要
子宫内膜异位症(EMS)是妇科常见病,近年来发病率逐年上升,仅次于子宫肌瘤。虽然为良性疾病,却表现为恶性行为,主要特征为疼痛、不孕及性交困难,导致生活质量下降。其治疗目的在于消除病灶、缓解疼痛和解决生育问题,降低术后复发也不可忽视,因此,药物治疗尤为重要,不同的药物有不同的作用机理、副作用及用药时间。不同的患者需要根据其治疗目的、身体情况及经济状况选择不同的治疗方案。所以药物治疗应注意个体化、阶梯化和规范化。本文就近年来内异症的药物治疗做一综述。
In recent years,the incidence of endometriosis (EMS) rises year by year, which is a common disease in department of gynaecology and inferior to hysteromyoma. Although it is a benign disease, it shows malignant act, that is pain, sterility,difficult sex, etc. In this paper,medication of the patients with EMS, in the past years, has been summarize&It is suggested that different patients should be given different treating plans according to their states of health, financial situations as well as treating purposes.
出处
《现代生物医学进展》
CAS
2007年第2期318-320,共3页
Progress in Modern Biomedicine
关键词
子宫内膜异位症
药物治疗
Endometriosis (EMS)
Medication
Incidence